Gene Guided Precision Nutrition test for Muscle Wasting

A Unique Genetic Test Identifying a Subset of the Population with a Genetic Signature Who Break Down Muscle (Rhabdomyolysis) While Exercising

Partner with Us
animate-top-right
animate-top-left
animate-bottom-right

Test Background

Up to 10% of the population has difficulty maintaining muscle mass due to variant genes. SNP Therapeutics has developed a genetic test and algorithm that can identify a subset of the population who are unable to maintain muscle mass due to SNPs preventing the proper metabolism of one carbon nutrients.

Gene Guided Nutri Big Image
  • Gene Guided Nutri Icon Muscle Wasting Market Opportunity

    Thirty two million americans suffer with muscle wasting. The market is forecast to grow to nearly $4Bn by 2024.

  • Gene Guided Nutri Icon Potential Markets

    SNP Therapeutics is well positioned to participate in this growing market with potential products focusing in the Sports Nutrition and Aging Consumer Health segments.

  • Gene Guided Nutri Icon Clinical Research

    SNP Therapeutics is seeking partnerships to develop clinical studies focused on identifying and treating athletes, the elderly, as well as military patient populations.

Contact Us to Start a Conversation

Precision nutrition muscle wasting genetic test

Contact
Partners